FDA has approved what St. Jude Medical (St. Paul, MN) calls the first U.S. heart failure device to suppress atrial fibrillation (AF). The device, called the Atlas II + HF cardiac resynchronization therapy defibrillator, has a special algorithm that helps control the heart's atrial rhythm. It does this by pacing slightly faster than the patient's natural heart rate, according to the company.
March 21, 2007
1 Min Read
Nearly 5 million Americans experience heart failure and about 40% of patients who have heart failure also have AF, cites St. Jude in a news release.
Sign up for the QMED & MD+DI Daily newsletter.
You May Also Like